Psychiatry and Neurology, Neurology · Austin, TX
NPI
1831307289
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
711 W 38th St, Building F
Austin, TX, 78705
Phone (512) 458-6121
Medicare paid, 2024
$106K
12,247 services
Medicare patients, 2024
178
Average age 75
Drug cost, 2024
$1.2M
2,074 prescriptions
Company payments, 2025
$2,950
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hana Aubrechtova was code J0585 (injection, onabotulinumtoxina, 1 unit), 9,500 times for 20 patients. In total Hana Aubrechtova billed 12,247 services in 20 codes, and Medicare paid $106K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-05-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 9,500 | 20 | $4.92 | $47K |
| 99214 Office E&M - Established | Office | 121 | 83 | $87.51 | $11K |
| 99213 Office E&M - Established | Office | 81 | 65 | $62.26 | $5,043 |
| 99205 Office E&M - New | Office | 51 | 51 | $154.93 | $7,901 |
| 64615 Musculoskeletal | Office | 42 | 15 | $122.11 | $5,128 |
| 95819 Neurologic | Office | 39 | 39 | $364.64 | $14K |
| 99215 Office E&M - Established | Office | 12 | 12 | $132.71 | $1,593 |
By year: 2022 $112K for 11,719 services; 2023 $117K for 14,236 services; 2024 $106K for 12,247 services.
Medicare prescription drug claims, 2024
In 2024, the drug Hana Aubrechtova prescribed most often to Medicare patients was Gabapentin, with 111 prescriptions and refills. In total Hana Aubrechtova wrote 2,074 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 111 | 208 | 30 | $2,103 |
| Duloxetine Hcl Generic | 79 | 178 | 22 | $2,273 |
| Topiramate Generic | 76 | 189 | 22 | $685 |
| Aimovig Autoinjector Erenumab-Aooe | 69 | 107 | 11 | $77K |
| Donepezil Hcl Generic | 64 | 188 | 27 | $992 |
| Emgality Pen Galcanezumab-Gnlm | 62 | 93 | Under 11 | $61K |
| Pregabalin Generic | 61 | 104 | 15 | $1,074 |
| Rytary Carbidopa/Levodopa | 56 | 68 | Under 11 | $34K |
| Divalproex Sodium Er Divalproex Sodium | 54 | 61 | Under 11 | $2,053 |
| Zonisamide Generic | 48 | 120 | 14 | $1,734 |
| Memantine Hcl Generic | 44 | 102 | 13 | $1,328 |
| Escitalopram Oxalate Generic | 44 | 94 | 15 | $475 |
| Carbamazepine Er Carbamazepine | 43 | 113 | 12 | $8,317 |
| Lacosamide Generic | 41 | 75 | Under 11 | $5,476 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 41 | 88 | Under 11 | $982 |
Brand drugs: 479 claims; generic drugs: 1,595 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hana Aubrechtova $2,950 ($2,950 in general payments such as food, travel and fees) from 27 companies. The largest payer was LivaNova USA, Inc. with $720.
| Company | Payments | Amount |
|---|---|---|
| LivaNova USA, Inc. LIVN | 12 | $720 |
| Abbvie Inc. ABBV | 20 | $342 |
| Novartis Pharmaceuticals Corporation NVS | 14 | $298 |
| Biogen, Inc. BIIB | 12 | $269 |
| SK Life Science, Inc. | 6 | $154 |
| Genentech USA, Inc. ROG.SW | 8 | $145 |
| Teva Pharmaceuticals USA, Inc. TEVA | 4 | $130 |
| Lilly USA, LLC LLY | 5 | $104 |
| TG Therapeutics, Inc. TGTX | 3 | $96.28 |
| Pfizer Inc. PFE | 5 | $92.56 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.